Prevalence of persistent lipid abnormalities in statin-treated patients: Belgian results of the Dyslipidaemia International Study (DYSIS)

AIM: A substantial number of cardiovascular events are not prevented by statin therapy, which is still regarded as the first-line therapy for hyperlipidaemia. Insights into the prevalence of lipid abnormalities of statin-treated patients in Belgium are lacking and may shed light on an unmet medical...

Descripción completa

Detalles Bibliográficos
Autores principales: Devroey, D, Radermecker, R P, Van der Schueren, B J, Torbeyns, B, Jaken, R J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Cardiovascular
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4265243/
https://www.ncbi.nlm.nih.gov/pubmed/24308644
http://dx.doi.org/10.1111/ijcp.12315

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4265243/
https://www.ncbi.nlm.nih.gov/pubmed/24308644
http://dx.doi.org/10.1111/ijcp.12315

Ejemplares similares